GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly gaining a major focus in therapeutic research, largely due to its notable impact on treating ailments such as type 2 diabetes and obesity. Recent research have revealed that more than glucose regulation, GLP-1 agonists offer p